Fukumoto, T., Park, P. H., Wu, S., Fatkhutdinov, N., Karakashev, S., Nacarelli, T., . . . Zhang, R. (2018). Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer. Cell Rep.
Styl ChicagoFukumoto, Takeshi, et al. "Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer." Cell Rep 2018.
Citace podle MLAFukumoto, Takeshi, et al. "Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer." Cell Rep 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..